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Introduction
Primary Synovial Sarcoma of the Lung 
Daniel J. Boulter, M.D., Melissa L. Rosado-de-Christenson, M.D., Robert Stevens, M.D., Saul 
Suster, M.D.
We describe a case of primary pulmonary synovial sarcoma. A 19-year-old man presented with low-
grade fever, dyspnea, chest pain and left arm numbness. Chest radiographs revealed a large, well-
circumscribed left perihilar mass and a small ipsilateral pleural effusion. Chest computed tomography 
(CT) revealed a large well-defined, heterogeneous lung mass. Magnetic resonance imaging (MRI) dem-
onstrated a mass of heterogeneous signal intensity on T1-weighted and proton density images, and high 
signal intensity on short tau inversion recovery (STIR) images. Whole-body bone scintigraphy showed 
no evidence of skeletal involvement. Abdominal and pelvic CT showed no intra-abominal or pelvic me-
tastases. A CT-guided biopsy provided the diagnosis of monophasic synovial sarcoma. Following four 
cycles of chemotherapy, integrated F-18 fluorodeoxyglucose positron emission tomography-computed 
tomography (18F FDG PET/CT) was performed, which demonstrated interval decrease in the size of 
the lesion and no significant metabolic activity. Surgical resection was then undertaken. Microscopi-
cally, the lesion was a high-grade spindle cell sarcoma consistent with monophasic synovial sarcoma. A 
variant X;18 translocation was identified by cytogenetic analysis and confirmed with metaphase in situ 
hybridization. The imaging and pathological features of this rare lesion are reviewed.
Synovial sarcomas typically occur as primary neoplasms 
of the periarticular soft tissues, but have also been reported 
to arise from a variety of other locations [1]. The lung and 
pleura have recently been identified as sites of primary 
synovial sarcoma [2, 3]. Primary pulmonary sarcomas of 
all varieties total less than 0.5% of all lung malignancies, of 
which synovial sarcoma is being reported with increasing 
frequency [4]. Pulmonary metastases from extrapulmo-
nary synovial sarcoma are far more common than primary 
pulmonary synovial sarcomas. Affected patients undergo a 
thorough analysis of clinical history, physical examination, 
and imaging findings to exclude a primary malignancy 
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Figure 1. 19-year-old man with primary synovial sarcoma 
of the lung. AP chest radiograph shows a large well circum-
scribed mass in the left mid lung and a small left pleural 
effusion.
A B
Figure 2. A, B, Contrast-enhanced chest CT (mediastinal window) shows a well circumscribed heterogeneous left lung mass abut-
ting the left hilum and pericardium. The lesion exhibited soft tissue and low attenuation components, the latter with fluid-fluid 
levels consistent with cystic change.
elsewhere. Although reports of primary pulmonary syn-
ovial sarcoma have increasingly appeared in the pathol-
ogy literature, few reports of the imaging features of this 
unusual neoplasms have been published [5]. We present a 
case of primary synovial sarcoma of the lung in a 19-year-
old man with particular emphasis on the radiologic and 
pathologic findings of this rare lesion.
Case Report
A 19-year-old man was referred to our institution for 
evaluation of a lung mass detected on chest radiography 
performed for assessment of dyspnea and low-grade fever. 
The patient described a six-week period of intermittent 
dull chest pain alternating with brief periods of palpita-
tions, severe chest pain, and numbness and tingling 
radiating down his left arm. His past medical history was 
notable only for a week-long episode of cough productive 
of dark green sputum 6 months previously, for which no 
evaluation or intervention was sought. The patient was 
a nonsmoker with no history of radiation or chemical 
exposures. His vital signs and physical examination were 
unremarkable. Electrocardiography and pulmonary func-
tion tests were within normal limits. Sputum and blood 
cultures grew Neisseria meningitidis, which was treated 
with ciprofloxacin. All other laboratory data were within 
normal limits.
Chest radiography revealed a large, left lung mass with 
well-defined margins and a small left pleural effusion (Fig. 
1). Contrast-enhanced chest CT (Fig. 2) demonstrated a 
well-defined, heterogeneous ovoid lung mass in the left 
lung that measured 8.9 by 9.5 cm. The lesion involved the 
left upper and lower lobes, abutted the left major fissure, 
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left hilum, and posterior aspect of the pericardium and 
produced mass effect on the central tracheobronchial tree. 
Irregular, enhancing tissue elements were appreciated 
within the lesion as well as low attenuation areas and fluid-
fluid levels (Fig. 2A). No intratumoral calcifications were 
detected. Surrounding ground glass opacity was noted in 
the lung adjacent to the lesion, likely related to relaxation 
atelectasis. Trace left pleural effusion was also present. No 
other abnormalities of the mediastinum, thoracic lymph 
nodes, or contralateral lung were identified. The diagnoses 
of primary pulmonary sarcoma and primary lung cancer 
were considered. Pleuropulmonary blastoma and intrapul-
monary germ cell neoplasm were also suggested in view 
of the internal cystic and heterogeneous appearance of the 
lesion. On subsequent thoracic magnetic resonance imag-
ing (MRI) the mass showed heterogeneous signal inten-
sity on T1-weighted and proton density pulse sequences 
(Figs. 3A, B). Short tau inversion recovery (STIR) images 
revealed areas of relatively high signal intensity within the 
mass. Contrast-enhanced fast gradient echo sequences 
demonstrated heterogeneous enhancement of the lesion 
with peripheral polylobular enhancement and enhancing 
tissue septa surrounding low signal intensity areas that 
likely corresponded to necrosis (Figs. 3C, D). Whole body 
bone scintigraphy using intravenous technetium-99m 
labeled methylene diphosphonate (MDP) showed mini-
mal radiopharmaceutical uptake within the lesion itself 
and no convincing evidence of osseous metastatic disease. 
Contrast-enhanced CT of the abdomen and pelvis showed 
no evidence of intra-abdominal or pelvic metastatic disease 
or other primary malignancy. 
An endoluminal lesion was not detected on bronchos-
copy. Bronchial aspirate cytology and endobronchial 
frozen section biopsies were negative for malignancy. A 
CT-guided biopsy showed malignant spindle cell sarcoma 
consistent with monophasic synovial sarcoma. Medical 
and surgical oncologists agreed to treat the tumor with 
four cycles of neoadjuvant ifosfamide and adriamycin 
chemotherapy prior to resection with the goal of reducing 
the size of the mass. A preoperative restaging whole-body 
fluorine-18 fluorodeoxyglucose integrated PET-CT study 
was performed (Fig. 4) after completion of chemotherapy, 
which demonstrated reduction in the size of the lesion 
from 8.9 by 9.5 cm to 7.8 by 4.7 cm. This pre-operative 
study showed no significant metabolic activity within the 
lesion, with a peak standardized uptake value (SUV) of 
1.3. A left pneumonectomy and lymph node dissection 
were performed. The tumor was noted to be located cen-
trally within the left upper lobe, crossed the major fissure, 
and was densely adherent to the adjacent pulmonary artery 
and inferior pulmonary vein.
The tumor specimen was described as a 7.6 x 7.0 x 6.4 
cm well circumscribed tan and fleshy to rubbery mass with 
focal areas of softening and hemorrhage. The cut surface 
was multicystic in appearance, and the mass abutted the 
left lower lobe. All five resected lymph nodes were negative 
for malignancy, and the surgical resection margin was free 
of tumor. Microscopically (Fig. 5), the tumor showed a 
dense, monotonous and atypical spindle cell proliferation 
consistent with high-grade monophasic synovial sarcoma. 
The tumor exhibited extensive areas of hemorrhage, strom-
al hyalinization, and focal areas of necrosis - the latter were 
presumed to be the result of preoperative chemotherapy. 
Immunohistochemical stains showed focal positivity for 
cytokeratins (Fig. 6A) AE1/AE3, epithelial membrane 
antigen (EMA), cluster of differentiation (CD) 99, and 
strong positivity for bcl-2 (Fig. 6B) and calponin. Stains 
for smooth muscle actin (SMA), S-100 protein and CD34 
were negative. Ultrastructurally, the tumor showed oval 
to spindle cells displaying closely apposed cell membranes 
with frequent desmosome-type intercellular junctions. 
The cell nuclei were elongated and irregular with frequent 
indentations of the nuclear envelopes and peripheral mar-
gination of chromatin. Prominent eccentric nucleoli were 
also present. The cytoplasm of the cells contained numer-
ous organelles, including scattered ribosomes, intermediate 
filaments, mitochondria, Golgi apparatti, and prominent 
rough endoplasmic reticulum. Cytogenetic analysis con-
firmed the diagnosis of synovial sarcoma by demonstrating 
a variant X;18 translocation. This complex rearrangement 
resulted in an abnormal chromosome 1, which was the 
result of an insertion of most of the chromosome arm 18q 
with the proximal part of Xp inserted into the q-arm of the 
chromosome 1. This finding was confirmed by metaphase 
fluorescence in situ hybridization (FISH), yielding a final 
diagnosis of primary monophasic synovial sarcoma.
The patient’s postoperative course was complicated 
by pulmonary thromboembolic disease detected at CT 
pulmonary angiography on post-operative day number 
two and treated with anticoagulation. Following surgi-
cal resection of the tumor, two more cycles of adjuvant 
chemotherapy were administered.
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Figure 3. A, Axial, and B, coronal, double inversion recovery magnetic resonance images through the lesion demonstrate a het-
erogeneous mass in the left mid lung that abuts the ipsilateral hilum and displaces the hilar structures.
A B
A B
Figure 3. C, Axial, and D, coronal, contrast-enhanced fast gradient echo sequences through the lesion demonstrate heteroge-
neous signal with medially located nodular enhancement and enhancing tissue septa and areas of low signal intensity that 
correlated with the cystic changes observed on CT.
Discussion
Synovial sarcoma is a malignant mesenchymal neoplasm 
that represents 10% of all primary malignant soft tissue 
tumors. It primarily affects the periarticular soft tissues 
of the extremities [6]. Despite initial thoughts that these 
tumors originated from synovial cells due to their common 
association with joints [6], recent literature suggests that 
synovial sarcoma is instead derived from pluripotential 
mesenchymal cells capable of aberrant epithelial differ-
entiation [2, 7, 8]. Among the observations that support 
this theory are reports of synovial sarcomas arising from a 
variety of locations, including the head and neck, mediasti-
num, heart, esophagus, and vulva [9]. Recently, the lung 
Primary Synovial Sarcoma of the Lung
RCR Radiology Case Reports | radiology.casereports.net 5 DOI: 10.2484/rcr.2007.v2i4.82
and pleura have been identified as sites of primary synovial 
sarcoma [2, 3]. Although synovial sarcoma only rarely in-
volves the lung primarily, reports of primary intrathoracic 
tumors have recently begun to accumulate likely due to an 
increasing ability to diagnose the tumors with immuno-
histochemical and cytogenetic techniques [4, 10]. Primary 
pulmonary sarcomas are responsible for less than 0.5% 
of all lung malignancies. The most commonly described 
histologic types include leiomyosarcoma, malignant 
fibrous histiocytoma, fibrosarcoma, and now, increasingly, 
synovial sarcoma [11]. The term “pleuropulmonary” was 
first recommended by Essary and colleagues to describe the 
anatomic subset of primary synovial sarcomas originating 
from either the lung or pleura due to inherent difficulties 
in assigning a precise anatomic origin in most cases [9]. A 
small but growing number of cases of primary pulmonary 
synovial sarcoma (PPSS) have been reported in the litera-
ture over the past decade, but very few of these reports 
focus on the imaging findings of this rare lesion [5, 11-15].
The radiologic features of PPSS have been enumer-
ated in a recent series by Frazier et al, and are briefly 
summarized here. Radiographically, PPSS is most com-
monly described as a pulmonary mass with either sharp 
or ill-defined borders, a pleural-based mass, or nearly total 
opacification of the affected hemithorax. Ipsilateral pleural 
effusion is common, and the contralateral lung is charac-
teristically not involved. Intratumoral calcifications have 
been reported once [3]. At CT, PPSS commonly manifests 
as a well-defined, heterogeneously enhancing mass with 
intrinsic areas of fluid attenuation, often with ipsilateral 
Figure 4. F-18 FDG PET/CT fused image following chemo-
therapy shows interval decrease in the size of the mass, 
decreasing mass effect on the adjacent hilum and very little 
metabolic activity (SUV of 1.3).
pleural effusion. Differentiation between lung and pleural-
based lesions at CT is often difficult, particularly with large 
lesions [3, 12, 16-18]. Associated lypmhadenopathy has 
rarely been reported [12, 19]. A peripheral rim of ground-
glass opacity surrounding the mass has been reported in 
one case [20]. In the few published MRI descriptions 
of the lesion, the appearance has varied from internally 
heterogeneous with intermediate signal intensity on T1-
weighted images with nodular areas of intermediate signal 
intensity on T2-weighted images to homogeneous hypoin-
tensity on both T1- and T2-weighted images [5, 11].
Patients with primary pulmonary synovial sarcoma most 
often present with chest pain, dyspnea, and cough. Up 
to 24% of patients are asymptomatic and are diagnosed 
because of an abnormality found incidentally on chest 
radiography [9]. In the largest series of 25 patients with 
synovial sarcoma, Zeren et al. reported that affected pa-
tients ranged in age from 16 to 77 years at diagnosis (mean 
age; 38.5 years) [2]. Our patient was young and presented 
with an atypical cluster of symptoms, including low-grade 
fever and left arm numbness. Synovial sarcoma metastatic 
to the lung is far more common than primary pulmo-
nary synovial sarcoma. The diagnosis of primary synovial 
sarcoma in the lung is supported by a thorough analysis of 
clinical history, physical examination, and imaging find-
ings that fails to detect a primary cancer elsewhere [21]. 
Our patient had no evidence of present or past soft tissue 
neoplasms and no localizing symptoms or physical exami-
nation findings suggestive of extra-pulmonary malignancy. 
Additionally, bone scintigraphy and CT examinations of 
the abdomen and pelvis showed no evidence of metastatic 
disease or other primary neoplasm. The treatment and 
clinical outcome of patients with PPSS have primarily 
been addressed anecdotally in the literature [11]. Synovial 
sarcomas of the lung are thought to behave in a more lo-
cally aggressive fashion than their soft tissue counterparts, 
perhaps due to inherent difficulties in obtaining adequate 
surgical margins combined with the tendency for affected 
patients to present late with minimal symptoms [9, 10]. 
The small number of published cases report treatment with 
surgical resection, combined with preoperative radiation or 
postoperative adjuvant chemotherapy.
Although the radiologic features of synovial sarcoma of 
the extremities are well-characterized [22-26], the imaging 
features of pleuropulmonary synovial sarcoma have not 
been well documented in the literature. Most reports have 
focused on radiographic and CT descriptions. Far fewer 
MRI or PET/CT descriptions have been published [5, 11, 
14, 15]. Frazier et al. reported the largest series (n = 12) 
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Figure 5. Photomicrograph (Hematoxylin and Eosin stain; 
original magnification 200 power) demonstrates a tumor 
composed of fascicles of monotonous atypical spindle cells 
with scattered mitoses (arrow).
of cases that categorized the imaging findings of primary 
PPSS. At chest radiography, seven lesions (N = 9) had 
sharply marginated borders with round, ovoid, or lobu-
lated contours. The most common CT findings were those 
of a heterogeneously enhancing mass with well-defined 
margins containing nodular soft-tissue components mixed 
with areas of low attenuation. Calcification and lymphade-
nopathy were not present, but ipsilateral pleural effusion 
was present in seven of eleven patients [11]. At MR imag-
ing, Frazier et al found that the most common appearance 
was that of a well-circumscribed mass with no evidence of 
spiculation or satellite nodules in three of three patients. 
An internally heterogeneous appearance on T1 was present 
in two of three patients combined with nodular areas of 
intermediate signal intensity and punctate or cystic areas 
of high signal intensity. At PET/CT, one case (N = 1) 
demonstrated focal increased uptake of FDG with maxi-
mum standardized uptake value (SUV) of 7.0. This finding 
differs significantly from our case, in which the PET/CT 
was performed after 4 cycles of neoadjuvant ifosfamide and 
adriamycin chemotherapy. The lesion at that time showed 
no hypermetabolic activity, with a peak SUV of 1.3. This 
finding could have implications in regards to re-staging of 
tumors and detection of distant metastases after treatment 
with chemotherapeutic agents. To our knowledge, this 
is the first report of a synovial sarcoma manifesting low 
metabolic activity on PET/CT after neoadjuvant chemo-
therapy. It should be noted that pre-treatment PET/CT 
was not performed.
The radiologic differential diagnosis of primary pulmo-
nary synovial sarcoma includes other primary and meta-
static lung neoplasms, localized fibrous tumors of the lung 
and pleura, pleuropulmonary blastoma, and other rare 
primary parenchymal sarcomas [11, 12]. A number of clin-
ical and radiologic features can help narrow the differential 
diagnosis. The presence of significant lymphadenopathy 
would favor the diagnosis of lung cancer over PPSS. Meta-
static disease rarely manifests as a large solitary pulmonary 
lesion, although thorough clinical and imaging evaluation 
must be undertaken to exclude this possibility. A number 
of other rare primary parenchymal sarcomas (fibrosarcoma, 
leiomyosarcoma, hemangiopericytoma, malignant nerve 
sheath tumor, sarcomatous carcinoma) cannot be reliably 
distinguished from synovial sarcoma based upon clinical 
and radiologic features alone.
In our case, the diagnosis of PPSS was established based 
on tissue obtained via CT-guided needle biopsy. A review 
of eight cases of primary pulmonary synovial sarcoma in 
the published literature in which preoperative biopsies 
were performed shows that the preoperative diagnosis of 
this lesion may be difficult to obtain. A diagnosis of prob-
able PPSS was made on only one CT-guided fine needle 
aspiration biopsy [27]. One CT guided biopsy showed a 
malignant non-epithelial tumor [5]. An ultrasound-guided 
needle biopsy showed a spindle cell tumor with a dif-
ferential diagnosis of synovial sarcoma or mesothelioma 
[28]. An unspecified fine needle aspiration biopsy showed 
atypical spindle cells and two unspecified needle biopsies 
showed malignant small round cells arranged in a heman-
giopericytomatous pattern [20] and non diagnostic find-
ings [29] respectively. Two bronchoscopic biopsies showed 
findings suggestive of mesenchymal tumor [15] and a 
spindle cell tumor not otherwise specified [30].
The pathologic features of pulmonary synovial sarco-
mas have been well described [9, 31, 32]. Histologically, 
synovial sarcoma is primarily divided into biphasic and 
monophasic subtypes. The monophasic variant is more 
common in the lung, and is composed entirely of spindle 
cells. The biphasic subtype consists of a combination of 
epithelial and spindle cells. In our case, the dense, mo-
notonous and atypical spindle cells without a glandular 
component were consistent with monophasic synovial 
sarcoma. The characteristic chromosomal translocation 
t(X;18)(SYT-SSX) is present in 80%-90% of these tumors 
and is considered specific for the diagnosis [10, 33, 34]. 
Detection of this translocation through cytogenetics and 
reverse transcriptase-polymerase chain reaction (RT-
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Figure 6. A, Immunoperoxidase stain for cytokeratin shows focal positivity in the tumor cells (KER, X200). B, Immunoperoxidase 
stain for bcl-2 protooncogene shows strong cytoplasmic positivity in the majority of the tumor cells (BCL-2, X200).
A B
PCR)-based techniques has greatly increased the sensitiv-
ity and specificity of the diagnosis of synovial sarcoma 
[10]. Immunohistochemically, most synovial sarcomas are 
positive for cytokeratins and or EMA. Vimentin is usually 
expressed in the spindle cell portions of the neoplasm, and 
S-100 reactivity can be identified in up to 30% of tumors. 
BCL-2 and CD99 are frequently positive, and CD34 is 
usually negative [31]. Our case showed typical immuno-
histochemical findings of synovial sarcoma. The t(X;18) 
translocation was detected with metaphase FISH analysis, 
confirming the diagnosis of synovial sarcoma.
The most important pathological differential diagnosis 
is metastatic disease. Additionally, other epithelial and 
mesenchymal tumors need to be differentiated from syn-
ovial sarcoma, including fibrosarcoma, leiomyosarcoma, 
hemangiopericytoma, peripheral nerve sheath tumors, sar-
comatous carcinoma, and intrapulmonary solitary fibrous 
tumors [2].
In summary, we have presented a case of primary pul-
monary synovial sarcoma in a young man who presented 
with symptoms referable to the chest and upper extrem-
ity. The diagnosis was established via a transthoracic CT 
guided needle biopsy. The patient underwent neoadjuvant 
chemotherapy prior to excision and post therapy integrat-
ed PET-CT demonstrated low metabolic activity in the 
tumor which also decreased in size. Pneumonectomy and 
lymph node dissection achieved tumor free margins. 
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